Latest Trials Latest NewsFAQ

ALCON RESEARCH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in Children 6 Months to 12 Years

Terminated

Conditions: Otorrhea

First Posted Date: 2010-04-28

Last Posted Date: 2012-02-02

Lead Sponsor: Alcon Research

Target Recruit Count: 1389

Registration Number: NCT01111877

Locations: 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Confirmatory Study Nepafenac 0.3%

Phase 3

Completed

Conditions: Cataract

Interventions: Drug: Nepafenac Ophthalmic Suspension, 0.3%
Drug: Nepafenac Ophthalmic Suspension, 0.1%
Other: Nepafenac Ophthalmic Suspension 0.3% Vehicle
Other: NEVANAC Vehicle

First Posted Date: 2010-04-23

Last Posted Date: 2012-11-30

Lead Sponsor: Alcon Research

Target Recruit Count: 2120

Registration Number: NCT01109173

Locations: 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

Phase 4

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Olopatadine hydrochloride ophthalmic solution 0.1%

First Posted Date: 2010-04-23

Last Posted Date: 2015-05-12

Lead Sponsor: Alcon Research

Target Recruit Count: 42

Registration Number: NCT01109485

Locations: 🇯🇵
Contact Alcon Call Center For Trial Locations, Tokyo, Japan

Efficacy of Systane Ultra in Post Menopausal Women With Dry Eye

Phase 4

Completed

Conditions: Post Menopausal Dry Eye Subjects

Interventions: Other: Systane Ultra Lubricant Eye Drops
Other: Sensitive Eyes Eye Drops (Bausch & Lomb)

First Posted Date: 2010-04-19

Last Posted Date: 2016-11-18

Lead Sponsor: Alcon Research

Target Recruit Count: 70

Registration Number: NCT01105910

A Comparative Pilot Study Of High-Order Aberrations With Aspheric IOL Models SN60WF and ZCB00

Not Applicable

Completed

Conditions: Cataracts

Interventions: Device: Tecnis 1-piece Aspheric Acrylic (ZCB00) IOL
Device: AcrySof Natural IQ (SN60WF) IOL

First Posted Date: 2010-04-16

Last Posted Date: 2012-11-29

Lead Sponsor: Alcon Research

Target Recruit Count: 20

Registration Number: NCT01105585

Locations: 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

Phase 3

Completed

Conditions: Blepharitis

Interventions: Drug: Tobradex ST
Drug: Azasite

First Posted Date: 2010-04-13

Last Posted Date: 2012-06-11

Lead Sponsor: Alcon Research

Target Recruit Count: 122

Registration Number: NCT01102244

Locations: 🇺🇸
Ora, Andover, Massachusetts, United States

Changes in Invitro and ex Vivo Lens Metrology With Daily Wear Contact Lenses

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Acuvue 2
Device: Purevision
Device: Air Optix Aqua
Device: Biofinity
Device: Proclear
Device: Acuvue Oasys

First Posted Date: 2010-04-09

Last Posted Date: 2012-07-18

Lead Sponsor: Alcon Research

Target Recruit Count: 35

Registration Number: NCT01100411

Locations: 🇦🇺
Institute for Eye Research, Sydney, New South Wales, Australia

Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining

Not Applicable

Completed

Conditions: Corneal Staining

Interventions: Device: Opti-Free RepleniSH
Device: ReNu MultiPlus
Device: Balafilcon A
Other: Unisol 4

First Posted Date: 2010-04-09

Last Posted Date: 2012-10-23

Lead Sponsor: Alcon Research

Target Recruit Count: 60

Registration Number: NCT01100424

Locations: 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects

Phase 4

Completed

Conditions: Dry Eye

Interventions: Other: Systane Ultra Lubricant Eye Drops

First Posted Date: 2010-03-15

Last Posted Date: 2012-02-02

Lead Sponsor: Alcon Research

Target Recruit Count: 10

Registration Number: NCT01086774

Evaluation of FID 114657 in Dry Eye Subjects

Not Applicable

Completed

Conditions: Meibomian Gland Dysfunction

Interventions: Other: FID 114657 (ORB Preserved Ocular Emulsion)

First Posted Date: 2010-03-03

Last Posted Date: 2012-02-02

Lead Sponsor: Alcon Research

Target Recruit Count: 49

Registration Number: NCT01079858

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy